Structure

InChI Key RRDRHWJDBOGQHN-JWCTVYNTSA-N
Smile CCC(C)CCCCC(=O)N(CS(=O)(=O)O)[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@@H](CN[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)O)NC1=O)[C@@H](C)O
InChI
InChI=1S/C59H114N16O30S6/c1-9-37(6)12-10-11-13-49(78)75(34-111(103,104)105)48(19-24-64-33-110(100,101)102)58(86)73-47(38(7)76)28-66-40(14-20-60-29-106(88,89)90)51(79)67-44-18-25-65-59(87)50(39(8)77)74-55(83)43(17-23-63-32-109(97,98)99)69-52(80)41(15-21-61-30-107(91,92)93)70-56(84)45(26-35(2)3)72-57(85)46(27-36(4)5)71-54(82)42(68-53(44)81)16-22-62-31-108(94,95)96/h35-48,50,60-64,66,76-77H,9-34H2,1-8H3,(H,65,87)(H,67,79)(H,68,81)(H,69,80)(H,70,84)(H,71,82)(H,72,85)(H,73,86)(H,74,83)(H,88,89,90)(H,91,92,93)(H,94,95,96)(H,97,98,99)(H,100,101,102)(H,103,104,105)/t37?,38-,39-,40+,41+,42+,43-,44+,45+,46-,47+,48+,50+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C59H114N16O30S6
Molecular Weight 1720.05
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
DISRUPTING AGENT Cell membrane disrupting agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteomyelitis 0 D010019 ClinicalTrials

Related Entries

Salt

Cross References

Resources Reference
CAS NUMBER 12705-41-8
ChEMBL CHEMBL2304327
FDA SRS DL2R53P963